✦ LIBER ✦

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone

✍ Scribed by Adrian V. Hernandez; Esteban Walker; John P.A. Ioannidis; Michael W. Kattan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of Cardiovascular Events in Patient

✍ William B. White; Christine R. West; Jeffrey S. Borer; Philip B. Gorelick; Lisa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Meta-Analysis of Aggression or Hostility

✍ John Polzer; Mark E. Bangs; Shuyu Zhang; Mary Anne Dellva; Sitra Tauscher-Wisnie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Effects of probiotics for the treatment

✍ Huang, Haohai; Song, Lijun; Zhao, Wenchang 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 274 KB

Fibrates in the prevention of cardiovasc

✍ Sandeep A. Saha; Rohit R. Arora 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Two topical calcineurin inhibitors for t

✍ Chen, Sheng-Li; Yan, Jun; Wang, Feng-Shan 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 339 KB

Re-evaluation of the risk for major adve

✍ T. Tzellos; A. Kyrgidis; C. C. Zouboulis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB